United States· US:57237-145_a4aff76f-e9a9-4300-b42c-616d8ca55d5d
Amlodipine and Benazepril Hydrochloride
A benazepril and amlodipine product containing amlodipine besylate; benazepril hydrochloride, registered in United States by Rising Pharma Holdings, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- Manufacturer
- Rising Pharma Holdings, Inc.
- Country
- United States (US)
- ATC code
- C09BB13
- ATC class
- Benazepril and amlodipine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc115723714501100 CAPSULE in 1 BOTTLE (57237-145-01)
- ndc115723714505500 CAPSULE in 1 BOTTLE (57237-145-05)
- ndc1157237-145-01
- ndc1157237-145-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C09BB13
Benazepril and amlodipine, as other registers publish it.
- United StatesAmlodipine and Benazepril HydrochloridePD-Rx Pharmaceuticals, Inc.
- United StatesAmlodipine and Benazepril HydrochlorideHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesAmlodipine and Benazepril HydrochlorideAurobindo Pharma Limited
- United StatesAmlodipine and Benazepril HydrochlorideREMEDYREPACK INC.
- United StatesAmlodipine and Benazepril HydrochlorideRising Pharma Holdings, Inc.
- United StatesAmlodipine and Benazepril HydrochlorideGolden State Medical Supply, Inc.
- United StatesAmlodipine and Benazepril HydrochlorideHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesAmlodipine and Benazepril HydrochlorideRising Pharma Holdings, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b546ec93-3490-4ae3-b191-a72e2341d9dd GET /v1/drugs/b546ec93-3490-4ae3-b191-a72e2341d9dd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5; 40",
"substance": "AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE",
"productndc": "57237-145",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA202239",
"marketing_category": "ANDA"
}See everything about benazepril and amlodipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.